Product Information
TRIAMCINOLONE 55 MCG NASAL SPR is a generic product labeled by Cardinal Health, priced at $0.7388 per ML under NDC 70000070201. Its NADAC has been published 59 times since Aug 20, 2025.
FDA first approved this application on Jan 19, 2023.
Strength
55 ug/1
Manufacturer
Cardinal HealthNDC
70000070201
Classification
Generic
Dosage Form
SPRAY, METERED
Route
NASAL
Effective Date
9/23/2026
Active Ingredients
TRIAMCINOLONE ACETONIDEApproval Type
Generic (ANDA)
FDA Application
ANDA214615FDA Approved
1/19/2023
On Market Since
6/3/2025
Pharmacological Classes
Price Statistics
The NADAC for TRIAMCINOLONE 55 MCG NASAL SPR has been published 59 times since Aug 20, 2025, and over the history we have for it it has risen 3.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7388 per ML |
|---|---|
| All-time high | $0.7720 (May 13, 2026) |
| All-time low | $0.7132 (Aug 20, 2025) |
| 52-week high | $0.7720 |
| 52-week low | $0.7136 |
| Median price | $0.7376 |
| Average price | $0.7393 |
| Largest weekly change | -2.9% (May 20, 2026) |
| Weeks tracked | 59 |
| Tracking since | Aug 20, 2025 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cardinal Health manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Triamcinolone acetonide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TRIAMCINOLONE 55 MCG NASAL SPR?
The current National Average Drug Acquisition Cost (NADAC) for TRIAMCINOLONE 55 MCG NASAL SPR, manufactured by Cardinal Health, is $0.7388 per ML (NDC 70000070201), effective Sep 30, 2026.
How has the price of TRIAMCINOLONE 55 MCG NASAL SPR changed over time?
Over the history we have for it, the NADAC for TRIAMCINOLONE 55 MCG NASAL SPR has risen 3.6%. It has been tracked across 59 weekly CMS publications since Aug 20, 2025.
What are the highest and lowest recorded NADAC prices for TRIAMCINOLONE 55 MCG NASAL SPR?
Since Aug 20, 2025, the NADAC for TRIAMCINOLONE 55 MCG NASAL SPR has ranged from a low of $0.7132 (Aug 20, 2025) to a high of $0.7720 (May 13, 2026), with a median of $0.7376 per ML.
Are there cheaper alternatives to TRIAMCINOLONE 55 MCG NASAL SPR?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NASAL ALLERGY 24HR SPRAY, is $0.7229 per ML — about 2% below TRIAMCINOLONE 55 MCG NASAL SPR.
Who manufactures TRIAMCINOLONE 55 MCG NASAL SPR?
TRIAMCINOLONE 55 MCG NASAL SPR (NDC 70000070201) is labeled by Cardinal Health, and CMS classifies it as a generic product.